Results 261 to 270 of about 4,081,422 (386)

No- and Low-Alcohol Wines: Perception and Acceptance in a Traditional Wine Region in Northern Italy. [PDF]

Foods
Akhtar W, Duley G, Calvia M, Longo E, Sait U, Boselli E.   +5 more
europepmc   +1 more source

Frailty Exacerbates Disability in Progressive Multiple Sclerosis

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Background To evaluate frailty in severe progressive multiple sclerosis (PMS) and to investigate the underlying mechanisms. Methods This prospective, cross‐sectional, multicenter study enrolled a late severe PMS group requiring skilled nursing (n = 53) and an age, sex, and disease duration‐matched control PMS group (n = 53).
Taylor R. Wicks, Anna Wolska, Diala Ghazal, Dejan Jakimovski, Bianca Weinstock‐Guttman, Alexander Burnham, Niels Bergsland, Michael G. Dwyer, Alan T. Remaley, Robert Zivadinov, Murali Ramanathan   +10 more
wiley   +1 more source

Influence of core self-evaluation on social anxiety in college students with financial difficulties: mediation of self-acceptance. [PDF]

Front Psychol
Chen YE, Lai LY.
europepmc   +1 more source

Real‐World Investigation of Satralizumab in Patients With Neuromyelitis Optica Spectrum Disease

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective Satralizumab, a monoclonal antibody targeting the interleukin‐6 receptor, has demonstrated efficacy in clinical trials for neuromyelitis optica spectrum disorder (NMOSD). However, its real‐world effectiveness and safety compared to conventional immunosuppressive therapies remain uncertain.
Li‐Tsung Lin, Hui‐An Lin, Sheng‐Feng Lin   +2 more
wiley   +1 more source

Inhibition of Classical and Alternative Complement Pathway by Ravulizumab and Eculizumab

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective To explore the feasibility of classical (CH50) and alternative (AH50) complement pathway activity as potential biomarkers for treatment guidance and monitoring during therapy with ravulizumab in patients with generalized myasthenia gravis (gMG) and compare these to therapeutic drug monitoring under eculizumab.
Lea Gerischer, Frauke Stascheit, Maximilian Mönch, Paolo Doksani, Carla Dusemund, Meret Herdick, Philipp Mergenthaler, Maike Stein, Amani Suboh, Jutta Schröder‐Braunstein, Guido Wabnitz, Jan D. Lünemann, Sophie Lehnerer, Sarah Hoffmann, Andreas Meisel   +14 more
wiley   +1 more source

Acceptance of disease as a mediator between social support and quality of life in women with Hashimoto's disease-a pilot study. [PDF]

Sci Rep
Bargiel-Matusiewicz K, Wnuk-Grzybowska M, Ziółkowska N, Łyś A.   +3 more
europepmc   +1 more source

Influential factors of B2B E-Commerce Acceptance in SMEs’ Structure and Process

, 2012
Taiseera Al-Balushi, Saqib Ali, Ruqaya Al Badi   +2 more
openalex   +1 more source

Deep Learning–Assisted Differentiation of Four Peripheral Neuropathies Using Corneal Confocal Microscopy

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective Peripheral neuropathies contribute to patient disability but may be diagnosed late or missed altogether due to late referral, limitation of current diagnostic methods and lack of specialized testing facilities. To address this clinical gap, we developed NeuropathAI, an interpretable deep learning–based multiclass classification ...
Chaima Ben Rabah, Ioannis N. Petropoulos, Mark Stettner, Maryam Ferdousi, Uazman Alam, Nathan Efron, Ahmed Serag, Rayaz A. Malik   +7 more
wiley   +1 more source

Perspectives on ageing acceptance among women in middle adulthood: a qualitative study. [PDF]

Int J Qual Stud Health Well-being
Gegieckaitė G, Rapolienė G, Kukulskienė M, Chonody J, Teater B.   +4 more
europepmc   +1 more source

Evaluating Acceptance of Mobile Money by Poor Citizens in India: An Empirical Study

, 2014
Sumedha Chauhan
openalex   +1 more source